EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deciphering PI4K2A: a key modulator in cellular signaling, autophagy, and disease pathogenesis

Xuedong Zhang, Di Zhang, Faxin Li, Jiting Lin, Tianhu Sun, Xiwen Pang, Chunxia Wang, Yifeng Chen, Weisheng Zhang, Tao Wang

Frontiers in Cell and Developmental Biology · 12.11.2026 · 14

DOI: 10.3389/fcell.2026.1909685 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 12.11.2026. Verfasst von Xuedong Zhang und 9 weiteren Autor:innen. Die Arbeit nennt 116 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Department of Gansu Province, Lanzhou Science and Technology Bureau.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphatidylinositol 4-kinase type 2 alpha (PI4K2A) is a key enzyme in phosphoinositide signaling and a central coordinator of membrane trafficking, autophagy and cellular signaling. Increasing evidence supports a role for PI4K2A in normal physiology and its dysregulation in pathological conditions, particularly neurological disorders and cancer. This review synthesizes the literature around the biological themes that define PI4K2A biology: its structure and membrane anchoring, its functions in membrane trafficking, autophagy and signaling, and its contributions to disease. We consolidate mechanistic evidence established in cell-based studies and then refer back to it when discussing disease associations, so that the mechanistic basis of each disease link is explicit. We also highlight the disagreements that remain unresolved—most importantly the apparently opposing pro-tumorigenic and anti-tumorigenic activities of PI4K2A, and the conflicting data on insulin secretion—and we set out the specific questions that define the current state of the field. Finally, we address potential therapeutic strategies targeting PI4K2A, aiming to offer novel insights into disease intervention. We propose that the value of PI4K2A as a therapeutic target depends on identifying the cellular contexts in which its inhibition is beneficial, which is now the central problem for the field.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Department of Gansu Province
  • Lanzhou Science and Technology Bureau

Zitieren

APA

Zhang, X., Zhang, D., Li, F., Lin, J., Sun, T., Pang, X., Wang, C., Chen, Y., Zhang, W., & Wang, T. (2026). Deciphering PI4K2A: a key modulator in cellular signaling, autophagy, and disease pathogenesis. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1909685

Vancouver

Zhang X, Zhang D, Li F, Lin J, Sun T, Pang X, et al. Deciphering PI4K2A: a key modulator in cellular signaling, autophagy, and disease pathogenesis. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1909685

BibTeX
@article{Zhang2026,
  author = {Zhang, Xuedong and Zhang, Di and Li, Faxin and Lin, Jiting and Sun, Tianhu and Pang, Xiwen and Wang, Chunxia and Chen, Yifeng and Zhang, Weisheng and Wang, Tao},
  title = {Deciphering PI4K2A: a key modulator in cellular signaling, autophagy, and disease pathogenesis},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  volume = {14},
  doi = {10.3389/fcell.2026.1909685}
}
Kostenlos starten →